Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;54(4):905-9.
doi: 10.1161/HYPERTENSIONAHA.109.137935. Epub 2009 Aug 24.

Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1

Affiliations

Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1

Babbette LaMarca et al. Hypertension. 2009 Oct.

Abstract

Agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA) and endothelin -1 (ET-1) are suggested to be important links between placental ischemia and hypertension during preeclampsia. Activation of the angiotensin II type 1 receptor (AT1R) increases endothelial cell production of ET-1; however, the importance of ET-1 in response to AT1-AA-mediated AT1 R activation during preeclampsia is unknown. Furthermore, the role of AT1-AA-mediated increases in blood pressure during pregnancy remains unclear. The objective of this study was to test the hypothesis that AT1-AA, increased to levels observed in preeclamptic women and placental ischemic rats, increases mean arterial pressure (MAP) by activation of the ET-1 system. Chronic infusion of purified rat AT1-AA into normal pregnant (NP) rats for 7 days increased AT1-AA from 0.68+/-0.5 to 10.88+/-1.1 chronotropic units (P<0.001). The increased AT1-AA increased MAP from 99+/-1 to 119+/-2 mm Hg (P<0.001). The hypertension was associated with significant increases in renal cortices (11-fold) and placental (4-fold) ET-1. To determine whether ET-1 mediates AT1-AA-induced hypertension, pregnant rats infused with AT1-AA and NP rats were treated with an ET(A) receptor antagonist. MAP was 100+/-1 mm Hg in AT1-AA+ET(A) antagonist-treated rats versus 98+/-2 mm Hg in ET(A) antagonist-treated rats. Collectively, these data support the hypothesis that one potential pathway whereby AT1-AAs increase blood pressure during pregnancy is by an ET-1-dependent mechanism.

PubMed Disclaimer

Figures

Figure 1
Figure 1
AT1-AA increase significantly in response to chronic infusion, indicated by increased beats per minute (bpm) of cultured rat neonatal cardiomyocyte assay. IgG was isolated from serum collected from NP and AT1-AA infused pregnant rats. The AT1-AA was column purified by epitope binding from the collection of IgG and activity tested by activation of AT1 receptors and increased chronotropic activity of cardiomyocytes in culture.
Figure 2
Figure 2
Changes in mean arterial pressure in normal pregnant (NP) rats in response to AT1-AA infusion. (* P<0.001 vs NP rats). Administration of either an ETA receptor antagonist or an AT1 receptor antagonist, losartan, abolished hypertension in response to AT1-AA in pregnant rats. All data are expressed as mean ±SEM.
Figure 3
Figure 3
Fold increase in tissue preproendothelin mRNA/B-actin determined by real time PCR. P values were <0.0073 in cortices (n=6) and < 0.02 in placenta (n=5). No difference was seen in medullary expression of ET-1 among the groups. AT1 receptor blockade significantly decreased preproendothelin in response to AT1-AA induced hypertension in renal cortices (n=6), and placenta (n=6).

Similar articles

Cited by

References

    1. Roberts JM, Lain KY. Recent Insights into the pathogenesis of pre-eclampsia. Placenta. 2002;23:359–372. - PubMed
    1. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension. 2003;41:437–445. - PubMed
    1. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, Juepner A, Gulba DC, Mackman N, Haller H, Luft FC. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation. 2000;101:2382–2387. - PubMed
    1. Dechend R, Viedt C, Muller DN, Ugele B, Brandes RP, Wallukat G, Park JK, Janke J, Barta P, Theuer J, Fiebeler A, Homuth V, Dietz R, Haller H, Kreuzer J, Luft FC. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation. 2003;107:1632–639. 1. - PubMed
    1. Dechend R, Muller DN, Wallukat G, Homuth V, Krause M, Dudenhausen J, Luft FC. Activating auto-antibodies against the AT1 receptor in preeclampsia. Autoimmun Rev. 2005;4:61–65. - PubMed

Publication types

MeSH terms